Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
105.098,62
0,23%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Ipsen SA (I7G) Ipsen SA (I7G) Notizie

Ipsen SA

I7G
119,20
-0,90 (-0,75%)
24 Gen 2025 - Chiuso
Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
07/1/202518:00UKREGIpsen - Bilan semestriel - 31 12 2024
07/1/202518:00UKREGIpsen - December 2024 - Monthly information relative to the..
07/1/202518:00UKREGIpsen - Half year statement - 2024 12 31
07/1/202518:00UKREGIpsen - Décembre 2024 - Information mensuelle relative au..
09/12/202418:00UKREGIpsen - November 2024 - Monthly information relative to the..
09/12/202418:00UKREGIpsen - Novembre 2024 - Information mensuelle relative au..
03/12/202407:00UKREGIpsen et Biomunex annoncent un accord de licence mondial..
03/12/202407:00UKREGIpsen and Biomunex announce exclusive global licensing..
18/11/202407:00UKREGBylvay® (odevixibat) data shows sustained improvement in..
18/11/202407:00UKREGBylvay® (odévixibat) montre une amélioration soutenue en..
15/11/202417:00UKREGIqirvo® (elafibranor) data shows efficacy and safety for up..
15/11/202417:00UKREGIqirvo® (elafibranor) montre des données d’efficacité et de..
07/11/202418:00UKREGIpsen - Octobre 2024 - Information mensuelle relative au..
07/11/202418:00UKREGIpsen - October 2024 - Monthly information relative to the..
23/10/202407:00UKREGIpsen delivers strong sales momentum in the first nine..
23/10/202407:00UKREGIpsen enregistre une forte dynamique commerciale au cours..
14/10/202418:00UKREGIpsen reçoit un deuxième prix Shingo pour son excellence..
14/10/202418:00UKREGIpsen receives its second Shingo Prize for operational..
09/10/202418:00UKREGIpsen - September 2024 - Monthly information relative to the..
09/10/202418:00UKREGIpsen - Septembre 2024 - Information mensuelle relative au..
23/9/202413:13UKREGLe médicament Kayfanda® (odévixibat) d’Ipsen est approuvé..
23/9/202413:13UKREGIpsen’s Kayfanda® (odevixibat) approved in European Union..
20/9/202414:57UKREGIpsen’s Iqirvo® (elafibranor) approved in the European Union..
20/9/202414:57UKREGLe médicament Iqirvo® (élafibranor) d’Ipsen est approuvé..
16/9/202414:45UKREGFinal results from CABINET Phase III trial reinforce..
16/9/202414:45UKREGLes résultats finaux de l’essai de Phase III CABINET..
15/9/202414:45UKREGIpsen provides update on CONTACT-02 Phase III trial in..
15/9/202414:45UKREGIpsen communique de nouvelles données sur l’essai de Phase..
04/9/202418:00UKREGIpsen - Août 2024 - Information mensuelle relative au nombre..
04/9/202418:00UKREGIpsen - August 2024 - Monthly information relative to the..
13/8/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024
13/8/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
06/8/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2024
06/8/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
05/8/202418:00UKREGIpsen - Juillet 2024 - Information mensuelle relative au..
05/8/202418:00UKREGIpsen - July 2024 - Monthly information relative to the..
30/7/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
30/7/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2024
26/7/202412:46UKREGIpsen reçoit des avis positifs du CHMP pour Iqirvo®..
26/7/202412:46UKREGIpsen receives CHMP positive opinions for Iqirvo®..
25/7/202414:18UKREGIpsen S.A.publie son Rapport financier semestriel 2024..
25/7/202414:18UKREGIpsen S.A. publishes its 2024 Half-Year Report (half-year..
25/7/202407:00UKREGIpsen publie de solides résultats pour le premier semestre..
25/7/202407:00UKREGIpsen delivers strong results in the first half of 2024,..
23/7/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
23/7/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2024
16/7/202418:00UKREGIPSEN - Achats effectués dans les conditions de l'Article 5..
16/7/202418:00UKREGIPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024
11/7/202407:00UKREGIpsen et Foreseen Biotechnology annoncent la signature d’un..
11/7/202407:00UKREGIpsen and Foreseen Biotechnology announce exclusive global..
Apertura: Min: Max:
Chiusura: 120,10

La tua Cronologia

TG
I7G
Ipsen
TG
1PX
Phoenix New Media
BIT
S28928
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network